መነሻ › የራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ › ሚሺጋን › Grand Rapids
በGrand Rapids፣ MI ለየራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለየራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ የሚደረጉ 15 ጥናቶች በGrand Rapids እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- BAMF Health, Grand Rapids
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- ALX Center 3, Grand Rapids
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- START Midwest, Grand Rapids
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Cancer & Hematology Centers of Western Michigan, Grand Rapids
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site, Grand Rapids
A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- START Midwest /ID# 272505, Grand Rapids
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- START Midwest, Grand Rapids
A Study of MGC026 in Participants With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- START Midwest, Grand Rapids
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- START Midwest, Grand Rapids
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
ተሳታዮችን በመፈለግ ላይደረጃ 1
- START Midwest /ID# 248685, Grand Rapids
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- START Midwest, Grand Rapids
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- START Midwest, Grand Rapids
በሌሎች ከተሞች ለየራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ የሚደረጉ ጥናቶች
- Houston, TX47 ጥናቶች
- Los Angeles, CA42 ጥናቶች
- Boston, MA40 ጥናቶች
- New York City, NY39 ጥናቶች
- Nashville, TN39 ጥናቶች
- St. Louis, MO28 ጥናቶች
- Arlington, VA26 ጥናቶች
- Philadelphia, PA26 ጥናቶች
- Chicago, IL26 ጥናቶች
- Atlanta, GA24 ጥናቶች
- San Antonio, TX22 ጥናቶች
- New Haven, CT22 ጥናቶች
በGrand Rapids ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር44 ጥናቶች
- የኮሎሬክታል ካንሰር40 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)28 ጥናቶች
- የጡንቻ ካንሰር26 ጥናቶች
- የእንቁላል ካንሰር24 ጥናቶች
- Metastatic Cancer22 ጥናቶች
- የፕሮስቴት ካንሰር19 ጥናቶች
- የኤንዶሜትሪየም ካንሰር18 ጥናቶች
- የሆድ ካንሰር18 ጥናቶች
- የፓንክሪያስ ካንሰር18 ጥናቶች
- ሜላኖማ17 ጥናቶች
- ትሪፕል-ኔጌቲቭ የደረት ካንሰር15 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።